Arbor Pharmaceuticals acquires XNPT for $7.03/sh in cash—a 60% premium to Friday’s closing price: http://finance.yahoo.com/news/arbor-pharmaceuticals-acquire-xenoport-103000592.html Arbor Pharmaceuticals is private. The nominal deal value is $467M.